Viewing Study NCT00346957


Ignite Creation Date: 2025-12-24 @ 6:47 PM
Ignite Modification Date: 2026-01-22 @ 10:28 PM
Study NCT ID: NCT00346957
Status: COMPLETED
Last Update Posted: 2012-03-06
First Post: 2006-06-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Study of Anecortave Acetate for the Treatment of Exudative Age-Related Macular Degeneration
Sponsor: Alcon Research
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: C-98-03
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators